Related Experiment Video
Updated: Mar 31, 2026

Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI
Published on: April 18, 2011
Restless leg syndrome exacerbated by amytriptiline in a patient with Duchenne Muscular Dystrophy
Ricardo Tera Akamine1, Luis Fernando Grossklauss2, Karen Tieme Nozoe3
1Sector of Neuromuscular Diseases Treatment/AFIP, São Paulo, SP, Brazil.
Abstract:
We report an unusual case of a Duchenne Muscular Dystrophy(DMD) patient who initiated a restless leg syndrome after the use of amytriptiline. The prescription and use of this medication for patients with persistent neuropathic pain is relatively common, especially for patients with DMD. Normally, this medication is well tolerated, however, we now report the occurrence of an induction or intensification of a restless leg syndrome case in a young patient with DMD, treated with amytriptiline for his chronic pain.
More Related Videos
09:18Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
Related Concept Videos
Restless Leg Syndrome and Night Terrors
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
REM Sleep Behavior Disorder
RBD is significantly associated with...
Skeletal Muscle Relaxants: Therapeutic Uses
Satellite Stem Cells and Muscular Dystrophy
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...